copper cu-64 dotatate · Curium · NDA 213227
Detectnet
Earliest generic entry, as listed
3 Sep 2041
Blocked by patent: US 12102696.
Listed patents · 4 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12102696 | product | 3 Sep 2041 |
| US 10383961 | use U-2951 | 2 Jul 2033 |
| US 10159759 | use U-2951 | 23 Aug 2032 |
| US 11160888 | use U-2951 | 23 Aug 2032 |
Exclusivities · 1 unexpired
| ODE-317 | orphan drug (7 years) | 3 Sep 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 213227 · 001 · RLD | solution, intravenous | 4mL (1mCi/ML) | 3 Sep 2041 |